{
  "meta": {
    "title": "Menopause",
    "url": "https://brainandscalpel.vercel.app/menopause-88381009.html",
    "scrapedAt": "2025-11-29T18:31:05.217Z"
  },
  "questions": [
    {
      "id": 12474,
      "choices": [
        {
          "id": 49860,
          "text": "<p><span style=\"font-size:12.0pt;\">Both Assertion and Reasoning are independently true/correct and Reason is the correct explanation of the Assertion</span></p>"
        },
        {
          "id": 49861,
          "text": "<p><span style=\"font-size:12.0pt;\">Both Assertion and Reasoning are independently true/correct and Reason is not the correct explanation of the Assertion</span></p>"
        },
        {
          "id": 49862,
          "text": "<p><span style=\"font-size:12.0pt;\">Assertion is independently a true/correct statement but the Reason is independently an incorrect/false statement</span></p>"
        },
        {
          "id": 49863,
          "text": "<p><span style=\"font-size:12.0pt;\">Assertion is independently a false/incorrect statement but the Reason is independently a true/correct statement</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\"><strong>Assertion:</strong> Hot flushes are common after menopause</span></p><p><span style=\"font-size:12.0pt;\"><strong>Reason:</strong> Estrogen withdrawal happens in menopause</span></p>",
      "unique_key": "Q2369471",
      "question_audio": null,
      "question_video": null,
      "map_id": 12325,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><strong>Ans. A. Both Assertion and Reasoning are independently true/correct and Reason is the correct explanation of the Assertion</strong></p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p><strong>Menopause</strong></p><p>&nbsp;</p><p>Menopause is defined as the cessation of ovarian function resulting in permanent amenorrhea. It takes 12 months of amenorrhea to confirm that menopause has set in.</p><p>&nbsp;</p><p><strong>Hot flushes</strong></p><ul style=\"list-style-type:disc;\"><li><strong>Most common</strong> symptom experienced</li><li>Hot flushes are the waves of vasodilation affecting face and neck lasting for 2-5 minutes followed by profuse sweating</li><li>Occur throughout the day, but severe at night</li><li>Symptoms – headache, palpitations, anginal pain&nbsp;</li><li>Cause: Oestrogen deficiency – reduces hypothalamic endorphins which release more norepinephrine and serotonin – inappropriate heat loss mechanism</li></ul><p>&nbsp;</p><p><strong>1. Lifestyle and Behavioral Measures (First-line for Mild Symptoms)</strong></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><strong>Wear light, layered clothing</strong></li><li><strong>Avoid triggers</strong>: spicy food, caffeine, alcohol, hot beverages</li><li><strong>Maintain a cool environment</strong></li><li><strong>Stress reduction techniques</strong>: yoga, mindfulness, CBT</li><li><strong>Regular exercise</strong></li></ul><p>&nbsp;</p><p><strong>2. Hormonal Therapy (Most Effective for Moderate to Severe Symptoms)</strong></p><p>&nbsp;</p><p><strong>A. Estrogen Therapy</strong></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><strong>Indicated</strong> for moderate-to-severe hot flushes</li><li><strong>Most effective treatment</strong></li><li>Given as <strong>systemic estrogen</strong> (oral/transdermal)</li><li>If <strong>uterus is intact</strong>, must be combined with <strong>progestogen</strong> to prevent endometrial hyperplasia</li></ul><p>&nbsp;</p><p><strong>B. Combined Estrogen + Progestogen Therapy</strong></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li>Indicated for women <strong>with a uterus</strong></li><li>Reduces vasomotor symptoms while protecting the endometrium</li></ul><p>&nbsp;</p><p><strong>C. Tibolone</strong></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li>Synthetic steroid with <strong>estrogenic, progestogenic, and androgenic</strong> properties</li><li>Effective for hot flushes, mood, and libido</li></ul><p>&nbsp;</p><p><strong>D. Transdermal Estrogen</strong></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li>Preferred in women with <strong>risk of VTE</strong> or <strong>liver disease</strong></li><li>Bypasses first-pass metabolism</li></ul><p>&nbsp;</p><p><strong>3. Non-Hormonal Pharmacologic Options</strong></p><p>&nbsp;</p><p>Recommended for women who <strong>cannot take hormones</strong> (e.g., history of breast cancer, VTE)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Vtto2bm.png\" width=\"949\" height=\"274\"></p><p>&nbsp;</p><p><strong>4. Complementary and Alternative Therapies</strong></p><p>&nbsp;</p><p>(Evidence is limited and mixed)</p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><strong>Isoflavones</strong> (soy, red clover): Phytoestrogens; mild benefit</li><li><strong>Black cohosh</strong>: Mixed evidence</li><li><strong>Acupuncture</strong>: Some women report benefit</li></ul><p>&nbsp;</p><p><strong>5. Newer Therapies</strong></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><strong>Fezolinetant</strong> (Neurokinin 3 receptor antagonist)<ul><li>FDA-approved nonhormonal drug for <strong>moderate-to-severe vasomotor symptoms</strong></li><li>Targets hypothalamic thermoregulation</li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Page 55, DC Duttas Textbook of Gynecology 8<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 49860,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12502,
      "choices": [
        {
          "id": 49972,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Atrophic vaginitis</span></span></span></p>"
        },
        {
          "id": 49973,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lichen planus</span></span></span></p>"
        },
        {
          "id": 49974,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lichen sclerosis</span></span></span></p>"
        },
        {
          "id": 49975,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Recurrent cervical cancer</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 48y woman comes to the clinic due to dyspareunia which has worsened over the last 4 months. Five years ago, she underwent chemoradiation for stage 2 cervical cancer. She has only recently resumed sexual activity after a gap of about 5 years. Despite over the counter use of lubricants, she is till having pain. There is no postcoital bleeding. She is amenorrhoeic since the chemoradiation. On examination, the vaginal introitus is narrow and the vagina is pale. The cervix appears scarred but there is no growth or ulcer and does not bleed on touch. What is the likely cause of her dyspareunia?</span></span></p>",
      "unique_key": "Q4724246",
      "question_audio": null,
      "question_video": null,
      "map_id": 12344,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Atrophic Vaginitis</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This patient has atrophic vaginitis which is part of genitourinary syndrome of menopause</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is due to medically induced menopauses (post CT/RT)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Estrogen maintains the moisture, blood flow and collagen content of vulvo vaginal tissue and hypo-estrogenism (menopause) causes dryness and decreased elasticity in these tissues. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:14px\"><strong>Option B:</strong> Lichen planus (LP):&nbsp;</span><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">LP is a complex immunologic disease mediated by cytotoxic T-cells directed against basilar keratinocytes.The disease produces symptoms of soreness, burning, pain, pruritus, contact/post-coital bleeding, dyspareunia, discharge,</span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:14px\"><strong>Option C:</strong> Lichen sclerosis:&nbsp;</span><span style=\"font-size:14px\">​​​​​​​<span style=\"font-family:Arial,Helvetica,sans-serif\">Vulvar lichen sclerosus (VLS) is a chronic inflammatory dermatosis characterized by ivory-white plaques or patches with glistening surface commonly affecting the vulva and anus. Common symptoms are irritation, soreness, dyspareunia, dysuria, and urinary or fecal incontinence.</span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:14px\"><strong>Option D:</strong> Recurrent cervical cancer:&nbsp;</span><span style=\"font-size:14px\">​​​​​​​This would present as vaginal bleeding or a foul smelling disharge</span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Estrogen maintains the moisture, blood flow and collagen content of vulvo vaginal tissue and hypo-estrogenism&nbsp; (menopause) causes dryness and decreased elasticity in these tissues</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">HRT is indicated in women who have symotoms of vaginal dryness in the menopause</span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 49, DC Duttas Textbook of Obstetrics, 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 49972,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12462,
      "choices": [
        {
          "id": 49812,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Oligomenorrhea</span></span></span></p>"
        },
        {
          "id": 49813,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypomenorrhea</span></span></span></p>"
        },
        {
          "id": 49814,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Menorrhagia</span></span></span></p>"
        },
        {
          "id": 49815,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Polymenorrhea</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of these is seen in Asherman syndrome? </span></span></p>",
      "unique_key": "Q9953170",
      "question_audio": null,
      "question_video": null,
      "map_id": 12320,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Hypomenorrhea</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Asherman&rsquo;s syndrome (intra-uterine synechiae)&nbsp;is more common with secondary amenorrhea or hypomenorrhea.</span></span></span></li>\r\n</ul>\r\n\r\n<p><em><strong><span style=\"font-size:12pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></span></strong></em></p>\r\n\r\n<ul>\r\n\t<li><em><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:16px\"><span dir=\"ltr\" lang=\"EN-US\"><strong>Option A:</strong> Oligomenorrhoea (infrequent cycles): This is seen in anovular cycles like PCOS</span></span></span></em></li>\r\n\t<li><em><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:16px\"><span dir=\"ltr\" lang=\"EN-US\"><strong>Option C:</strong> Menorrhagia: This is heavy bleeding and is seen in fibroids, adenomyosis, Copper containing IUD&nbsp;</span></span></span></em></li>\r\n\t<li><em><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:16px\"><strong>Option D:</strong> Polymenorrhoea: This is frequent cycles and is seen in PID, thyroid disorders and in short luteal phase</span></span></em></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><em><strong>Educational Objective:</strong></em></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><em><strong>Asherman Syndrome&nbsp;</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:14px\"><strong><em>This is intrauterine synechiae</em></strong></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:14px\"><strong><em>Occurs due to:&nbsp;</em></strong></span>\r\n\t<ul>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometrial or cervical scarring (e.g. vigorous curettage)</span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infections &ndash; due to intrauterine device, tuberculosis, schistosomiasis</span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Severe pelvic inflammatory disease. </span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>C/F: </strong>HYpomenorrhoea or secondary amenorrhoea, infertility</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Diagnosis:</strong> </span></span></span>\r\n\t<ul>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">HSG: Irregular uterine cavity on HSG (moth eaten appearance)</span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hysteroscopy: Ix of choice: Adhesions are seen in the uterine cavity</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Treatment:</strong> Hysteroscopic adhesiolysis</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page 384, DC Duttas textbook of Gynecology, 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 49813,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12471,
      "choices": [
        {
          "id": 49848,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">It is effective for vasomotor symptoms during perimenopausal period</span></span></span></p>"
        },
        {
          "id": 49849,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">It should be given for young women with premature menopause</span></span></span></p>"
        },
        {
          "id": 49850,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">It is useful for primary prevention of heart disease</span></span></span></p>"
        },
        {
          "id": 49851,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">Cyclical HRT is preferred over continuous HRT in perimenopausal women</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which is incorrect regarding Hormone Replacement Therapy in menopause?</span></span></p>",
      "unique_key": "Q5358725",
      "question_audio": null,
      "question_video": null,
      "map_id": 12324,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">Ans. C. It is useful for primary prevention of heart disease </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">Other Options</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">Option A:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">It is effective for vasomotor symptoms during perimenopausal period: The most common indication for HRT is vasomotor symptoms in the peri menopausa/ menopause</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><strong>Option B:</strong>&nbsp;It should be given for young women with premature menopause: Women who ave premature menopause (menopsuae &lt; 40y) should be started on HRT</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><strong>Option D:</strong>&nbsp;Cyclical HRT is preferred over continuous HRT in perimenopausal women: Cyclical HRT will ensure the patient gets regular cycles alongwith treating her symptoms in peri-menopausal women, Women who are post menopause are given continuous HRT to ensure amenorrhoea.&nbsp;</span></span></span></li>\r\n</ul>\r\n\r\n<p><em><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">Educational Objective:</span></span></span></strong></em></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hormone Replacement Therapy</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Indications of HRT</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Relief of vasomotor symptoms</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Prevention of osteoporosis </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">To maintain the quality of life in menopausal years </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Premature ovarian failure</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Gondal dysgenesis</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Surgical or radiation menopause</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">**Although HRT may be cardio protective, it is not given for prevention as the risks outweight the benefits</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">CONTRAINDICATIONS TO HRT </span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Undiagnosed genital tract bleeding </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Estrogen dependent neoplasm in the body </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">History of venous thromboembolism </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Active liver disease </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Gallbladder disease </span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MONITORING PRIOR TO AND DURING HRT </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A base level parameter of the following and their subsequent check up (at least annually) are mandatory. </span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Physical examination including pelvic examination. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Blood pressure recording. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Breast examination and Mammography. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cervical cytology </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pelvic ultrasonography (TVS) to measure endometrial thickness (normal &lt;5 mm). </span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Any irregular bleeding should be investigated thoroughly (endometrial biopsy, hysteroscopy). </span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ideal serum level of estradiol should be 100 pg/ml during HRT therapy. Serum level of estradiol is useful to monitor the HRT therapy rather than that of serum FSH. </span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page 51, DC Duttas Textbook of Gynecology 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 49850,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12488,
      "choices": [
        {
          "id": 49916,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hot flushes </span></span></span></p>"
        },
        {
          "id": 49917,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Night sweats</span></span></span></p>"
        },
        {
          "id": 49918,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Decrease libido </span></span></span></p>\r\n\r\n<p>&nbsp;</p>"
        },
        {
          "id": 49919,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Intermittent hypotension</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Symptoms of menopause are all except?</span></span></p>",
      "unique_key": "Q1708867",
      "question_audio": null,
      "question_video": null,
      "map_id": 12335,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. Intermittent hypotension</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MENOPAUSE</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Menopause is defined as the time of cessation of ovarian function, which leads to permanent cessation of menses.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It takes 12 months of cessation of menses to call as menopause.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypotension is not a sign of menopause</span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clinical Features of Menopause</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/28/screenshot-2023-04-28-152752_wE3VbqJ.jpg\" style=\"height:631px; width:822px\" /></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Indications of HRT</span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Relief of vasomotor symptoms</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Prevention of osteoporosis </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">To maintain the quality of life in menopausal years </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Premature ovarian failure</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Gondal dysgenesis</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Surgical or radiation menopause</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 49, DC Duttas Textbook of Obstetrics, 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 49919,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12491,
      "choices": [
        {
          "id": 49928,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ganirelix</span></span></span></p>"
        },
        {
          "id": 49929,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nafarelin</span></span></span></p>"
        },
        {
          "id": 49930,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Goserelin</span></span></span></p>"
        },
        {
          "id": 49931,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Triptorelin</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">All of the following are GnRH agonist except?&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></p>",
      "unique_key": "Q4478348",
      "question_audio": null,
      "question_video": null,
      "map_id": 12336,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Ganirelix</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ganirelix is a GnRH antagonist</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/28/screenshot-2023-04-28-153416.jpg\" style=\"height:264px; width:858px\" /></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Examples of GnRH agonists are leuprolide, buserelin, naferelin, goseriln and triptrelin</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Gynecological uses of GnRH agonists include</span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Precocious puberty</span></span></li>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Fibroids</span></span></li>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Endometriosis</span></span></li>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">In infertility in IVF pregnancies (as a trigger in place of hCG)</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref:&nbsp; Page no 442, DC Duttas Textbook of Obstetrics, 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 49928,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12498,
      "choices": [
        {
          "id": 49956,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Growth hormone + E + P </span></span></span></p>"
        },
        {
          "id": 49957,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Estrogen</span></span></span></p>"
        },
        {
          "id": 49958,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">No HRT needed</span></span></span></p>"
        },
        {
          "id": 49959,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">HRT only after 45 years</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 15y girl with primary amenorrhea is diagnosed to have Turner Syndrome. What Hormone replacement therapy should be given?</span></span></p>",
      "unique_key": "Q9111831",
      "question_audio": null,
      "question_video": null,
      "map_id": 12341,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Growth hormone + E + P</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">45XO is suggestive of Turners syndrome</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hormone Replacement in Turner Syndrome</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Growth hormone (GH) therapy has become the standard of care for girls with Turner Syndrome and should be considered as soon as decreased linear growth velocity is apparent.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Final adult height is maximized if GH therapy is begun at a young age; and is positively associated with the duration of treatment.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Recent studies have suggested that treatment initiated prior to 4 years of age significantly improved height outcome.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Most girls with Turner require hormone replacement therapy for breast development, uterine growth, and bone health.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The consensus is to initiate hormone replacement therapy at a time that coincides with normal female pubertal development.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Initial hormone replacement involves low dose estrogen monotherapy. Progestogen replacement is generally added 1&ndash;2 years after starting estrogen or upon breakthrough bleeding.</span></span></span></li>\r\n</ul>\r\n\r\n<p><em><strong>Educational Objective:&nbsp;</strong></em></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Most girls with Turner require hormone replacement therapy for breast development, uterine growth, and bone health.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The consensus is to initiate hormone replacement therapy at a time that coincides with normal female pubertal development.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Initial hormone replacement involves low dose estrogen monotherapy. Progestogen replacement is generally added 1&ndash;2 years after starting estrogen or upon breakthrough bleeding.</span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 374, DC Dutta&rsquo;s Textbook of Obstetrics, 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 49956,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12486,
      "choices": [
        {
          "id": 49908,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hot flushes </span></span></span></p>"
        },
        {
          "id": 49909,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ca breast</span></span></span></p>"
        },
        {
          "id": 49910,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Endometriosis </span></span></span></p>"
        },
        {
          "id": 49911,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Uterine bleeding</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hormonal replacement therapy is indicated in menopausal women for: </span></span></span></p>",
      "unique_key": "Q1673442",
      "question_audio": null,
      "question_video": null,
      "map_id": 12334,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Hot flushes</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Hormone Replacement Therapy</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Indications of HRT</span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Relief of vasomotor symptoms</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Prevention of osteoporosis </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">To maintain the quality of life in menopausal years </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Premature ovarian failure</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Gondal dysgenesis</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Surgical or radiation menopause</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Other Options</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><em><strong>Option B: Ca breast: </strong>Breast cancer is a c/i to HRT&nbsp;</em></span></li>\r\n\t<li><span style=\"font-size:14px\"><em><strong>Option C: Endometriosis: </strong>Endometriosis is not usually seen in the menopause but even if the patient has symptoms of endometriosis post menopause, HRT is not given due to the estrogen component</em></span></li>\r\n\t<li><span style=\"font-size:14px\"><em><strong>Option D: </strong>Uterine Bleeding: Unexplained bleeding is a c/i to HRT</em></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Indications of HRT</span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Relief of vasomotor symptoms</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Prevention of osteoporosis </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">To maintain the quality of life in menopausal years </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Premature ovarian failure</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Gondal dysgenesis</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Surgical or radiation menopause</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C/i to HRT</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><em><span style=\"font-size:14px\">A history of breast cancer or endometrial cancer</span></em></li>\r\n\t<li><em><span style=\"font-size:14px\">Severe liver disease</span></em></li>\r\n\t<li><em><span style=\"font-size:14px\">Thromboembolic disorders</span></em></li>\r\n\t<li><em><span style=\"font-size:14px\">Undiagnosed vaginal bleeding</span></em></li>\r\n\t<li><em><span style=\"font-size:14px\">Endometriosis</span></em></li>\r\n\t<li><em><span style=\"font-size:14px\">Hypertriglyceridemia</span></em></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 49, DC Duttas Textbook of Obstetrics, 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 49908,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12468,
      "choices": [
        {
          "id": 49836,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">5 mm</span></span></span></span></p>"
        },
        {
          "id": 49837,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">1.6 mm </span></span></span></span></p>"
        },
        {
          "id": 49838,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">3 mm</span></span></span></span></p>"
        },
        {
          "id": 49839,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">2 mm</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presents with postmenopausal bleed. Endometrial biopsy will be done if <span style=\"color:black\">endometrial thickness is?</span></span></span></p>",
      "unique_key": "Q8801278",
      "question_audio": null,
      "question_video": null,
      "map_id": 12321,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. 5 mm </span></strong></span></span></p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/28/screenshot-2023-04-28-152131.jpg\" style=\"height:735px; width:778px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><em><strong>Educational Objective:</strong></em></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Causes of postmenopausal bleeding</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Abnormal perimenopausal and postmenopausal bleeding should always be taken seriously and be properly investigated.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Invasive tumors of the cervix, vagina and vulva are usually evident on local and Speculum examination and any lesion identified should be biopsied.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">If any visible cervical growth </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:Wingdings\">&agrave;</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> biopsy &iexcl;s taken for histology.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">If cervix apparently looks normal </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:Wingdings\">&agrave;</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> cervical and endocervical smear to exclude dysplasia or CIN.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The possibility of uterine source of bleeding must always be eliminated.</span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Uterine Causes of Postmenopausal Bleeding&nbsp; </span></strong></span></span></p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/28/screenshot-2023-04-28-152154.jpg\" style=\"height:263px; width:700px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page 469, DC Duttas Textbook of Gynecology 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 49836,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12476,
      "choices": [
        {
          "id": 49868,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Presence of hot flushes </span></span></span></p>"
        },
        {
          "id": 49869,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cessation of menses for 1 year</span></span></span></p>"
        },
        {
          "id": 49870,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cessation of menses for 6 months </span></span></span></p>"
        },
        {
          "id": 49871,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cessation of menses for 2 years</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Menopause is defined as? </span></span></p>",
      "unique_key": "Q7699306",
      "question_audio": null,
      "question_video": null,
      "map_id": 12326,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Cessation of menses for 1 year</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong>Educational Objective:</strong></em></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MENOPAUSE</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Menopause is defined as the time of cessation of ovarian function, which leads to permanent cessation of menses.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It takes 12 months of cessation of menses to call as menopause.</span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clinical Features of Menopause</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/28/screenshot-2023-04-28-152752.jpg\" style=\"height:631px; width:822px\" /></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page 49, DC Duttas Textbook of Gynecology 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 49869,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12503,
      "choices": [
        {
          "id": 49976,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Transvaginal ultrasound</span></span></span></p>"
        },
        {
          "id": 49977,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Perform endometrial ablation</span></span></span></p>"
        },
        {
          "id": 49978,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Stop the estrogen patch and place an LNG-IUD</span></span></span></p>"
        },
        {
          "id": 49979,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Schedule a hysterectomy</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 54y woman presents to the OPD with several months of irregular vaginal spotting. She does not give a history of heavy bleeding but only that her undergarments are stained with blood. She attained menopause at the age of 52 and she had hot flushes and night sweats for which she was started on the transdermal estrogen patch and progesterone only pills. She has been consistently using the estrogen patches but stopped the progesterone in view of severe nausea. She has no significant medical history. She is on regular HPV screening and her last HPV was done 2 year earlier which was normal. Speculum exam reveals a normal cervix and vagina with minimal blood in the upper vagina. Bimanual exam reveals a small uterus with no adnexal mass. What is the next best step in management?</span></span></p>",
      "unique_key": "Q6140322",
      "question_audio": null,
      "question_video": null,
      "map_id": 12345,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Transvaginal ultrasound </span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The probable cause of this patients bleeding is endometrial atrophy/ malignancy due to unopposed estrogen</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">She requires a Transvaginal scan to see the endometrial thickness and if &gt; 5mm, an endometrial biopsy should be done</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">HRT in women with a uterus should always be given Estrogen + Progesterone as Estrogen alone can lead to endometrial hyperplasia</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In hysterectomized women, Estrogen alone can be given</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options</span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Option A:&nbsp;</strong>Perform endometrial ablation: Without knowing the cause of bleeding, ablation will not be done. Endometria ablation is done in women with AUB where malignancy has been excluded</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Option B:</strong>&nbsp;Stop the estrogen patch and place an LNG-IUD: Estrogen is the treatment for hot flashes. Progesterone is added to prevent endometrial hyperplasia and malignancy. Simply putting an LNG-IUD will not solve her problems and without ruling out atypia or malignancy, LNG-IUD cannot be put.</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Option C:</strong> Schedule a hysterectomy: A hysterectomy is done only if there is endometrial atypia or malignancy.&nbsp;</span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><strong>Educational Objective:&nbsp;</strong></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">HRT in women with a uterus should always be given Estrogen + Progesterone as Estrogen alone can lead to endometrial hyperplasia</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In hysterectomized women, Estrogen alone can be given</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 49, DC Duttas Textbook of Obstetrics, 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 49976,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12504,
      "choices": [
        {
          "id": 49980,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bisphosphonates</span></span></span></p>"
        },
        {
          "id": 49981,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Calcium + Vitamin D supplementation</span></span></span></p>"
        },
        {
          "id": 49982,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Estrogen + Progesterone</span></span></span></p>"
        },
        {
          "id": 49983,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Teriparatide</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 60y woman presents for a routine checkup. She has a sedentary lifestyle and her BMI is 26. She used to smoke 1 pack/ day but has recently stopped. She was advised calcium and vitamin D supplementation at her last checkup but has not been taking these. She has no significant medical history. A DEXA scan is done which shows her T score as -2.5. What is the most appropriate treatment option for her?</span></span></span></p>",
      "unique_key": "Q4612387",
      "question_audio": null,
      "question_video": null,
      "map_id": 12346,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Bisphosphonates </span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A T score of &gt; -2.5 is indicative of Osteoporosis </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">As she also has several risk factors (postmenopausal, h/o smoking, not taking ca and vit D), she is at an increased risk of fractures</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The drug of choice for treatment of Osteoporosis is Bisphosphonates</span></span></span></li>\r\n</ul>\r\n\r\n<p><em><strong>Other Options:&nbsp;</strong></em></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Option B:</strong> Calcium and vit D should also be advised to all post-menopausal women so although this option is correct too, a better option is bisphosphonates</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Option C:</strong> HRT (e + P) can be given to prevent Osteoporosis but is not the 1<sup>st</sup> line drug of choice</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Option D: </strong>Teriparatide is recombinant parathormone and is given in women who have not responded to bisphosphonates. </span></span></span></li>\r\n</ul>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:&nbsp;</span></span></span></strong></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The drug of choice for treatment of Osteoporosis is Bisphosphonates</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 49, DC Duttas Textbook of Obstetrics, 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 49980,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12500,
      "choices": [
        {
          "id": 49964,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Delay in return of fertility after contraception</span></span></span></p>"
        },
        {
          "id": 49965,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sheehan syndrome</span></span></span></p>"
        },
        {
          "id": 49966,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Premature ovarian failure</span></span></span></p>"
        },
        {
          "id": 49967,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Secondary amenorrhea due to hypothyroidism</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 32-year-old woman complains that she has not had a period for 3 months. Four home pregnancy tests have all been negative. She started her periods at the age of 15 years and until 30 years she had a normal 28-day cycle. She had one daughter by normal delivery 2 years ago, following which she breast-fed for 6 months. After that she had normal cycles again for several months and then her periods stopped abruptly. She was using the progesterone only pill for contraception while she was breastfeeding and stopped 6 months ago as she is keen to have another child. She reports symptoms of dryness during intercourse and has experienced sweating episodes at night as well as episodes of feeling extremely hot at any time of day. The only medical history of note is that she has been hypothyroid for 10 years and takes thyroxine 100 mg per day. She does not take any alcohol, smoke or use recreational drugs. On lab investigation FSH level is 45 IU/L. what is the diagnosis? </span></span></span></p>",
      "unique_key": "Q4878200",
      "question_audio": null,
      "question_video": null,
      "map_id": 12342,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C. Premature ovarian failure </span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This woman has symptoms of amenorrhoea as well as hypo-oestrogenic vasomotor symptomsand vaginal dryness. The diagnosis is of premature menopause (premature ovarian failure),confirmed by the very high FSH levels. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Premature ovarian failure is defined as cessation of due to loss of function of the ovaries before the age of 40 years</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">FSH and LH will be high (FSH &gt; 20)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Estradiol levels will be low.&nbsp;&nbsp;</span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Other Options:&nbsp;</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Option A: </strong>Stopping progesterone pills does not cause a delay in return to&nbsp;fertility. Amongst all temporary contraceptives, Inj DMPA causes a delayed return to fertility</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Option B:</strong> In Sheehan syndrome, she would have had reduced FSH levels asn it is due to pituitary failure. Here the FSH is high meaning it is an ovarian cause.&nbsp;</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Option D:</strong> Hypothyroidism is also unlikely in this scenario as she has been taking her medication and hypothyroidism will present as intolerance to cold (inability to stay warm). Hyperthyroidism may present with sweating and hot flushes. FSH levels will not be&nbsp;high in hypothyroidism or hyperthyroidism</span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong><span style=\"font-family:Calibri,sans-serif\">Educational Objective:</span></strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Premature ovarian failure is defined as cessation of due to loss of function of the ovaries before the age of 40 years</span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">FSH and LH will be high (FSH &gt; 20)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Estradiol levels will be low</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Page no 395, DC Dutta&rsquo;s Textbook of Obstetrics, 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 49966,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}